Rayzebio, Inc.

Not Rated
  • Market Cap: Small Cap
  • Industry: Biotechnology
  • ISIN: US75525N1072
USD
62.49
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Rayzebio, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
Profit Before Tax
-68.00
-29.00
-6.00
Adjustment
0.00
0.00
0.00
Changes In working Capital
2.00
1.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
Cash Flow from Operating Activities
-51.00
-31.00
-2.00
Cash Flow from Investing Activities
-27.00
-171.00
-3.00
Cash Flow from Financing Activities
157.00
109.00
149.00
Net Cash Inflow / Outflow
78.00
-93.00
143.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Rayzebio, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-68.6
-248.602
180.00
72.41%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
2.516
24.081
-22.00
-89.55%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-51.681
-192.25
141.00
73.12%
Cash Flow from Investing Activities
-27.215
-23.796
-4.00
-14.37%
Cash Flow from Financing Activities
157.543
252.396
-95.00
-37.58%
Net Cash Inflow / Outflow
78.647
36.665
42.00
114.50%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.315
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'22
stock-summary

YoY Growth in year ended Dec 2022 is -66.04% vs -1,234.73% in Dec 2021

Dec'22
Dec'21
Change(%)
Cash Flow from Operating Activities
-51.68
-31.13
-66.04%